Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2020-11-05 Investor Presentation
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Investor Presentation Q2 FY2021
Investor Presentation Classification · 100% confidence The document is titled 'Q2 FY2021 Investor Presentation' and is addressed to stock exchanges pursuant to SEBI regulations, indicating it is a formal investor communication. It contains detailed financial data for the quarter Q2 FY2021, including sales, EBITDA, profit after tax, and segment performance. The content includes forward-looking statements, strategic vision, operational highlights, and market performance metrics. The length is substantial (15,000 characters), and the document is a presentation format with slides and charts. It is not a full annual or interim report but a detailed presentation aimed at investors summarizing quarterly financial results and business updates. Therefore, the document fits the category of an Investor Presentation (IP).
2020-11-05 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated November 4, 2020, reporting unaudited financial results for Lupin Limited for the quarter and half year ended September 30, 2020. It includes detailed financial highlights, income statement data, balance sheet highlights, and operational commentary. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure of financial results. The content is comprehensive and contains actual financial data and analysis for a quarterly period, not just a brief announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2020-11-04 English
Lupin Quarter II FY2021 Results.
Regulatory Filings
2020-11-04 English
Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2020.
Interim / Quarterly Report Classification · 95% confidence The document is dated November 4, 2020, and references the approval of unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2020. It mentions compliance with SEBI Listing Regulations, including Regulation 30 and 33, which pertain to disclosure of financial results. The document includes detailed financial tables with revenue, expenses, profit before tax, tax expense, and net profit after tax for the quarter and six months ended September 30, 2020, as well as comparative figures for previous periods. It also references a Limited Review Report by the statutory auditors, which is typical for quarterly or interim financial results. The presence of detailed financial data and analysis for a period shorter than a full fiscal year (quarter and half-year) confirms this is a comprehensive interim financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2020-11-04 English
Financial Result Updates
Regulatory Filings
2020-11-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, only placeholders and an omitted image. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, the document cannot be classified as a report or announcement type. It fits best as a Regulatory Filing (RNS) fallback category due to absence of content.
2020-10-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.